Axe Compute ROE 2012-2026 | AGPU
Current and historical return on equity (ROE) values for Axe Compute (AGPU) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Axe Compute ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $-0.24B | $0.00B | -10622.22% |
| 2025-12-31 | $-0.23B | $-0.01B | 3006.45% |
| 2025-09-30 | $-0.08B | $-0.02B | 425.32% |
| 2025-06-30 | $-0.01B | 0 | 0.00% |
| 2025-03-31 | $-0.01B | $0.00B | -666.67% |
| 2024-12-31 | $-0.01B | $0.00B | -480.00% |
| 2024-09-30 | $-0.01B | $0.01B | -288.89% |
| 2024-06-30 | $-0.01B | $0.01B | -185.71% |
| 2024-03-31 | $-0.01B | $0.01B | -143.59% |
| 2023-12-31 | $-0.01B | $0.01B | -96.30% |
| 2023-09-30 | $-0.02B | $0.02B | -105.88% |
| 2023-06-30 | $-0.02B | $0.02B | -88.37% |
| 2023-03-31 | $-0.03B | $0.03B | -95.24% |
| 2022-12-31 | $-0.03B | $0.03B | -81.30% |
| 2022-09-30 | $-0.03B | $0.04B | -70.92% |
| 2022-06-30 | $-0.03B | $0.04B | -65.41% |
| 2022-03-31 | $-0.02B | $0.05B | -42.70% |
| 2021-12-31 | $-0.02B | $0.04B | -45.20% |
| 2021-09-30 | $-0.02B | $0.04B | -65.71% |
| 2021-06-30 | $-0.03B | $0.03B | -96.15% |
| 2021-03-31 | $-0.03B | $0.02B | -165.08% |
| 2020-12-31 | $-0.03B | $0.01B | -291.89% |
| 2020-09-30 | $-0.03B | $0.01B | -266.67% |
| 2020-06-30 | $-0.03B | $0.01B | -200.00% |
| 2020-03-31 | $-0.02B | $0.02B | -137.50% |
| 2019-12-31 | $-0.02B | $0.01B | -148.15% |
| 2019-09-30 | $-0.01B | $0.01B | -83.72% |
| 2019-06-30 | $-0.01B | $0.01B | -128.00% |
| 2019-03-31 | $-0.01B | $0.00B | -733.33% |
| 2018-12-31 | $-0.01B | $0.00B | -363.64% |
| 2018-09-30 | $-0.01B | $0.00B | -228.57% |
| 2018-06-30 | $-0.01B | $0.00B | -184.62% |
| 2018-03-31 | $-0.01B | $0.00B | -215.38% |
| 2017-12-31 | $-0.01B | $0.00B | -200.00% |
| 2017-09-30 | $-0.01B | $0.00B | -240.00% |
| 2017-06-30 | $-0.01B | $0.00B | -300.00% |
| 2017-03-31 | $-0.01B | $0.00B | -400.00% |
| 2016-12-31 | $-0.01B | $0.00B | -560.00% |
| 2016-09-30 | $-0.01B | $0.00B | -400.00% |
| 2016-06-30 | $-0.01B | $0.00B | -228.57% |
| 2016-03-31 | $-0.01B | $0.00B | -342.86% |
| 2015-12-31 | $0.00B | $0.00B | 800.00% |
| 2015-09-30 | $0.00B | $0.00B | 133.33% |
| 2015-06-30 | $0.00B | $-0.01B | 72.73% |
| 2015-03-31 | $-0.01B | $-0.01B | 105.26% |
| 2014-12-31 | $-0.01B | $0.00B | 186.67% |
| 2014-09-30 | $-0.01B | $0.00B | 233.33% |
| 2014-06-30 | $-0.01B | $0.00B | 444.44% |
| 2014-03-31 | $-0.01B | $0.00B | 400.00% |
| 2013-12-31 | $-0.01B | $0.00B | 360.00% |
| 2013-09-30 | $-0.01B | $0.00B | 360.00% |
| 2013-06-30 | $-0.01B | $0.00B | 290.91% |
| 2013-03-31 | $-0.01B | $0.00B | 360.00% |
| 2012-12-31 | $-0.01B | $0.00B | 320.00% |
| 2012-09-30 | $-0.01B | $0.00B | 360.00% |
| 2012-06-30 | $-0.01B | $0.00B | 280.00% |
| 2012-03-31 | $-0.01B | $0.00B | 200.00% |
| 2011-12-31 | $0.00B | $0.00B | 177.78% |
| 2011-09-30 | $0.00B | $0.00B | 50.00% |
| 2011-06-30 | $0.00B | $0.00B | 0.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | 50.00% |
| 2010-09-30 | $0.00B | $0.00B | 50.00% |
| 2010-06-30 | $0.00B | $0.00B | 100.00% |
| 2010-03-31 | $0.00B | $0.00B | 200.00% |
| 2009-12-31 | $0.00B | $0.00B | 300.00% |
| 2009-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.022B | $0.000B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |